MedPath

A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer

Phase 3
Completed
Conditions
Prostate Cancer Metastatic
Interventions
Biological: PROSTVAC-V
Biological: PROSTVAC-F
Biological: Placebo
Other: GM-CSF Placebo
Registration Number
NCT01322490
Lead Sponsor
Bavarian Nordic
Brief Summary

The purpose of this study is to determine whether PROSTVAC alone or in combination with GM-CSF is effective in prolonging overall survival in men with few or no symptoms from metastatic, castrate-resistant prostate cancer.

Detailed Description

BNIT-PRV-301 is a randomized, placebo-controlled, multi-center, global Phase 3 efficacy trial of PROSTVAC in men with asymptomatic or minimally symptomatic, metastatic, castrate-resistant prostate cancer. It is a 3-arm study and will evaluate overall survival in two separate comparisons, PROSTVAC plus adjuvant dose GM-CSF versus controls, and PROSTVAC without GM-CSF versus controls.

Patients will be randomized with equal probability into one of three double-blind arms. The intended interventions for randomized patients are:

1. (Arm V+G) PROSTVAC-V/F plus adjuvant dose GM-CSF

2. (Arm V) PROSTVAC-V/F plus GM-CSF placebo

3. (Arm P) Double placebo

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
1297
Inclusion Criteria

Men, ≥18years of age with documented asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer.

Documented progressive disease post surgical castration or during androgen suppression therapy, or during complete androgen blockade therapy and withdrawal. Documented by either criterion a (Radiological progression), OR criterion b (PSA progression).

  1. Radiological progression defined as any new/enlarging bone metastases or new/enlarging lymph node disease, consistent with prostate cancer.

    OR

  2. PSA progression defined by sequence of rising values separated by > 1 week (2 separate increasing values) over a threshold minimum of 2.0 ng/ml. (PCWG2 PSA eligibility criteria).

Chemotherapy naïve and Vaccinia-experienced (previous smallpox vaccination). Currently using a GnRH agonist or antagonist (unless surgically castrated).

Exclusion Criteria

Cancer-related pain requiring scheduled opioid narcotics for control (as needed, ≤ 2x per week is allowed).

Metastasis to organ systems other than lymph nodes and/or bone. Estimated PSA doubling time of <1 month as established within 6 months of the anticipated first dose of vaccine or placebo.

Concurrent or prior Provenge (sipuleucel-T) immunotherapy for prostate cancer. Receipt of an investigational agent within 30 days (or 60 days for an antibody-based therapy) of the first planned dose of PROSTVAC-V/F.

History of prior malignancies other than prostate cancer within the past 3 years, excluding successfully resected basal or squamous cell carcinoma of the skin.

Congestive heart failure (NYHA Class II, III, or IV), unstable angina, ventricular or hemodynamically significant atrial arrhythmia, or cardiovascular disease such as stroke or myocardial infarction (current or within the past 6 months) Confirmed positive for HIV, hepatitis B, and /or hepatitis C. Immunodeficiency or splenectomy. History of or active autoimmune disease, persons with vitiligo are not excluded. Diabetics are not excluded if the condition is well controlled.

History of atopic dermatitis or active skin condition (acute, chronic, exfoliative) that disrupts the epidermis.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PROSTVAC-V/F-TRICOM + GM-CSFPROSTVAC-V* PROSTVAC-V-TRICOM * PROSTVAC-F-TRICOM * GM-CSF
PROSTVAC-V/F-TRICOM + GM-CSFPROSTVAC-F* PROSTVAC-V-TRICOM * PROSTVAC-F-TRICOM * GM-CSF
PROSTVAC-V/F-TRICOM + GM-CSF placeboGM-CSF Placebo* PROSTVAC-V-TRICOM * PROSTVAC-F-TRICOM * GM-CSF placebo
Placebo ControlGM-CSF PlaceboPROSTVAC V/F Placebo + GM-CSF Placebo
Placebo ControlPlaceboPROSTVAC V/F Placebo + GM-CSF Placebo
PROSTVAC-V/F-TRICOM + GM-CSF placeboPROSTVAC-V* PROSTVAC-V-TRICOM * PROSTVAC-F-TRICOM * GM-CSF placebo
PROSTVAC-V/F-TRICOM + GM-CSF placeboPROSTVAC-F* PROSTVAC-V-TRICOM * PROSTVAC-F-TRICOM * GM-CSF placebo
PROSTVAC-V/F-TRICOM + GM-CSFGM-CSF* PROSTVAC-V-TRICOM * PROSTVAC-F-TRICOM * GM-CSF
Primary Outcome Measures
NameTimeMethod
Overall SurvivalRandomization through the date of death due to any cause. Subjects were followed up for approximately 6 years from the first subject randomized to the completion of the study.

The time between the date of randomization and the date of death due to any cause. Subjects who did not experience death or the competing events of "definite" loss to follow-up or withdrawal of consent were right censored at the date of last contact. OS was calculated using the formula: OS = Date of death/competing event/censoring - date of randomization + 1.

Secondary Outcome Measures
NameTimeMethod
Number of Subjects Alive Without Event at 6 MonthsRandomization through Week 25/End of Treatment visit.

A binary assessment that was performed for the 6-months timepoint for the categories of radiographic progression, pain progression, initiation of chemotherapy or death. Subjects without an event prior to 6-months were evaluated at 6-months. Subjects without event by 6-months and were not evaluated at 6-months were assumed to have had an event and analyzed as such.

Progression events were defined as: (1) Two new lesions on bone scan, new metastases on CT scans, or an increased size of nodal lesions per RECIST 1.1. Bone or CT scans occurring prior to calendar month 6 were used to determine radiographic progression. (2) Introduction of scheduled opioid narcotics for cancer-related pain control. (3) Initiation of chemotherapy for prostate cancer was assessed as collected on progression forms as well as in cancer treatment and concomitant medications logs. (4) Death.

Trial Locations

Locations (219)

Alaska Clinical Research Center, Llc

🇺🇸

Anchorage, Alaska, United States

Scottsdale Healthcare

🇺🇸

Scottsdale, Arizona, United States

Alta Bates Summit Medical Center

🇺🇸

Berkeley, California, United States

Prostate Oncology Specialists, Inc.

🇺🇸

Marina Del Rey, California, United States

Desert Hematology-Oncology

🇺🇸

Rancho Mirage, California, United States

San Bernardino Urological Associates

🇺🇸

San Bernardino, California, United States

Stanford Advanced Medical Center

🇺🇸

Stanford, California, United States

South Florida Medical Research

🇺🇸

Aventura, Florida, United States

Manatee Medical Research Institute, LLC

🇺🇸

Bradenton, Florida, United States

Florida Urology Physicians

🇺🇸

Fort Myers, Florida, United States

First Urology PSC

🇺🇸

Jeffersonville, Indiana, United States

Pinellas Urology, Inc.

🇺🇸

Saint Petersburg, Florida, United States

Palm Beach Cancer Institute

🇺🇸

West Palm Beach, Florida, United States

Lakeland Regional Cancer Center

🇺🇸

Lakeland, Florida, United States

North Idaho Urology

🇺🇸

Coeur d'Alene, Idaho, United States

Northern Indiana Cancer Research Consortium

🇺🇸

South Bend, Indiana, United States

The Iowa Clinic, PC Iowa Urology

🇺🇸

West Des Moines, Iowa, United States

Tulane University

🇺🇸

New Orleans, Louisiana, United States

Myron Murdock M.D. LLC

🇺🇸

Greenbelt, Maryland, United States

Kansas City VA Medical Center

🇺🇸

Kansas City, Missouri, United States

University Urology Associates

🇺🇸

New York, New York, United States

The Cancer Institute of New Jersey

🇺🇸

New Brunswick, New Jersey, United States

Brooklyn Urology Research Group

🇺🇸

Brooklyn, New York, United States

Presbyterian Hospital Center for Cancer Research

🇺🇸

Charlotte, North Carolina, United States

Hudson Valley Urology, P.C.

🇺🇸

Poughkeepsie, New York, United States

Northeast Urology Research

🇺🇸

Concord, North Carolina, United States

Gabrail Cancer Center

🇺🇸

Canton, Ohio, United States

W.G. (Bill) Hefner VA Medical Center

🇺🇸

Salisbury, North Carolina, United States

Urologic Consultants of Southeaster PA LLP

🇺🇸

Bala-Cynwyd, Pennsylvania, United States

Willamette Valley Cancer Center

🇺🇸

Springfield, Oregon, United States

Urological Associates Of Lancaster

🇺🇸

Lancaster, Pennsylvania, United States

Mount Nittany Medical Center

🇺🇸

State College, Pennsylvania, United States

Greenville Hospital System

🇺🇸

Greenville, South Carolina, United States

Ralph H Johnson VAMC

🇺🇸

Charleston, South Carolina, United States

WJB Dorn VA Medical Center

🇺🇸

Columbia, South Carolina, United States

Carolina Urologic Research Center

🇺🇸

Myrtle Beach, South Carolina, United States

University of TN Medical Center

🇺🇸

Knoxville, Tennessee, United States

The West Clinic, P.C.

🇺🇸

Memphis, Tennessee, United States

James H. Quillen Veterans Affairs Medical Center

🇺🇸

Mountain Home, Tennessee, United States

Central Texas Veterans Health Care System

🇺🇸

Temple, Texas, United States

Scott and White Memorial Hospital

🇺🇸

Temple, Texas, United States

White River Junction Veterans Affairs Medical Center

🇺🇸

White River Junction, Vermont, United States

Virginia Oncology Associates PC

🇺🇸

Norfolk, Virginia, United States

Washington Cancer Institute

🇺🇸

Washington, District of Columbia, United States

Ochsner Cancer Institute

🇺🇸

New Orleans, Louisiana, United States

Delaware Valley Urology LLC - Westhampton

🇺🇸

Mount Laurel, New Jersey, United States

VA Sierra Nevada HealthCare System

🇺🇸

Reno, Nevada, United States

Madigan Army Medical Center

🇺🇸

Tacoma, Washington, United States

The Schiffler Cancer Center

🇺🇸

Wheeling, West Virginia, United States

Calvary Mater Newcastle

🇦🇺

Waratah, New South Wales, Australia

Redcliffe Hospital

🇦🇺

Redcliffe, Queensland, Australia

Royal Adelaide Hospital

🇦🇺

Adelaide, South Australia, Australia

Austin Hospital

🇦🇺

Heidelberg, Victoria, Australia

Monash Medical Centre - Moorabbin Campus

🇦🇺

Bentleigh East, Australia

St John of God Hospital

🇦🇺

Subiaco, Australia

Barwon Health

🇦🇺

Geelong, Australia

Border Medical Oncology

🇦🇺

Wodonga, Australia

Princess Alexandra Hospital

🇦🇺

Woolloongabba, Australia

Ziekenhuisnetwerk Antwerpen - AZ Middelheim

🇧🇪

Antwerp, Belgium

Cliniques Universitaires Saint-Luc

🇧🇪

Brussels, Belgium

Institut Jules Bordet

🇧🇪

Bruxelles, Belgium

AZ Maria Middelares

🇧🇪

Gent, Belgium

UZ Leuven

🇧🇪

Leuven, Belgium

H.-Hartziekenhuis Roeselare-Menen vzw

🇧🇪

Roeselare, Belgium

Brantford Urology Research

🇨🇦

Brantford, Ontario, Canada

Capital District Health Authority

🇨🇦

Halifax, Nova Scotia, Canada

Southern Interior Medical Research Inc.

🇨🇦

Kelowna, British Columbia, Canada

Cambridge Memorial Hospital

🇨🇦

Cambridge, Ontario, Canada

St. Josephs Healthcare Hamilton Research Ethics Board

🇨🇦

Hamilton, Ontario, Canada

The Female/Male Health Centres

🇨🇦

Oakville, Ontario, Canada

London Health Sciences Centre

🇨🇦

London, Ontario, Canada

Centre Hospitalier Universitaire de Quebec Hotel Dieu

🇨🇦

Quebec, Canada

Centre Hospitalier de l'Universite de Montreal

🇨🇦

Montreal, Quebec, Canada

North Estonia Medical Centre Foundation

🇪🇪

Tallinn, Estonia

Centre Hospitalier Départemental La Roche sur Yon, Luçon, Montaigu - Les Oudaries

🇫🇷

La Roche Sur Yon, France

East Tallinn Central Hospital

🇪🇪

Tallinn, Estonia

Tartu University Hospital

🇪🇪

Tartu, Estonia

Centre Paul Papin

🇫🇷

Angers, France

Centre d'Oncologie de Gentilly

🇫🇷

Nancy, France

Centre Léon Bérard - Centre régional de lutte contre le cancer Rhône-Alpes

🇫🇷

Lyon, France

HIA du Val de Grâce

🇫🇷

Paris, France

Fondation Hôpital Saint-Joseph

🇫🇷

Paris, France

Institut Curie

🇫🇷

Paris, France

Centre Hospitalier Lyon Sud

🇫🇷

Pierre Benite, France

Institut Mutualiste Montsouris

🇫🇷

Paris, France

Institut Jean Godinot - Centre de lutte contre le cancer

🇫🇷

Reims, France

Clinique Armoricaine de Radiologie

🇫🇷

Saint Brieuc, France

Hôpital Bretonneau

🇫🇷

Tours, France

Centre Alexis Vautrin - Centre Régional de lutte contre le cancer de Lorraine

🇫🇷

Vandoeuvre les Nancy, France

Universitätsklinikum Bonn

🇩🇪

Bonn, Germany

Stadtisches Klinikum Muchen GmbH

🇩🇪

Munich, Bavaria, Germany

Klinikum der Johann-Wolfgang-Goethe-Universität Frankfurt am Main

🇩🇪

Frankfurt, Germany

Universitätsklinikum Essen

🇩🇪

Essen, Germany

Martini-Klinik am UKE GmbH

🇩🇪

Hamburg, Germany

Klinikum der Friedrich-Schiller-Universität Jena

🇩🇪

Jena, Germany

Chirurgische Universitätsklinik Freiburg

🇩🇪

Freiburg, Germany

Universitatsklinikum Ulm

🇩🇪

Ulm, Germany

Klinikum der Philipps-Universität Marburg

🇩🇪

Marburg, Germany

Universitätsmedizin der JGU Mainz

🇩🇪

Mainz, Germany

Studienpraxis Urologie

🇩🇪

Reutlingen, Germany

Universitätsklinikum Tübingen

🇩🇪

Tübingen, Germany

Landspitali University Hospital

🇮🇸

Reykjavik, Iceland

Universitätsklinikum Würzburg

🇩🇪

Würzburg, Germany

Universitätsklinikum Ulm

🇩🇪

Ulm, Germany

Soroka University Medical Center

🇮🇱

Beer Sheva, Israel

Bnei Zion Medical Center

🇮🇱

Haifa, Israel

Rambam Medical Center

🇮🇱

Haifa, Israel

Edith Wolfson Medical Center

🇮🇱

Holon, Israel

Hadassah University Hospital Ein Kerem

🇮🇱

Jerusalem, Israel

The Chaim Sheba Medical Center

🇮🇱

Ramat-Gan, Israel

Assaf Harofe Medical Center

🇮🇱

Tzrifin, Israel

NKI-AVL

🇳🇱

Amsterdam, Netherlands

VUMC

🇳🇱

Amsterdam, Netherlands

Academisch Ziekenhuis Maastricht

🇳🇱

Maastricht, Netherlands

Radboudumc

🇳🇱

Nijmegen, Netherlands

Erasmus MC

🇳🇱

Rotterdam, Netherlands

Urologica Praktyka Lekarska Adam Marcheluk

🇵🇱

Siedlce, Poland

AMEDS CENTRUM Sp. z o.o.

🇵🇱

Grodzisk Mazowiecki, Poland

Miedzyleski Szpital Specjalistyczny w Warszawie

🇵🇱

Warsaw, Poland

Szpital sw Elzbiety - Mokotowskie Centrum Medyczne Sp. z o. o.

🇵🇱

Warsaw, Poland

Alliance for Research and Knowledge

🇵🇷

San Juan, Puerto Rico

Chelyabinsk Regional Clinical Oncology Dispensary

🇷🇺

Chelyabinsk, Russian Federation

Klinika Urologii i Onkologii Urologicznej, Uniwersytecki Szpital Kliniczny we Wrocławiu

🇵🇱

Wroclaw, Poland

Arkhangelsk Regional Clinical Oncology Dispensary

🇷🇺

Arkhangelsk, Russian Federation

Ponce School of Medicine

🇵🇷

Ponce, Puerto Rico

Orel Oncology Center

🇷🇺

Orel, Russian Federation

Moscow Research Oncology Institute n.a. P.A.Gertsen

🇷🇺

Moscow, Russian Federation

St. Petersburg Medical Academy of Postgraduate Education

🇷🇺

St. Petersburg, Russian Federation

Kazan State Medical University

🇷🇺

Kazan, Russian Federation

Clinical Oncology Dispensary

🇷🇺

Omsk, Russian Federation

Orenburg Regional Clinical Oncology Center

🇷🇺

Orenburg, Russian Federation

St. Petersburg State Medical University n.a. I.P. Pavlov

🇷🇺

St. Petersburg, Russian Federation

"Orkli" LLC

🇷🇺

St. Petersburg, Russian Federation

City Hospital #15

🇷🇺

St. Petersburg, Russian Federation

"Clinic Andros" LLC

🇷🇺

St.Petersburg, Russian Federation

Regional Clinical Oncology Hospital

🇷🇺

Yaroslavl, Russian Federation

Regional Clinical Oncology Center

🇷🇺

Vladimir, Russian Federation

Stavropol Regional Clinical Oncology Dispensary

🇷🇺

Stavropol, Russian Federation

Hospital 12 de Octubre

🇪🇸

Madrid, Madrid, Communidad De, Spain

Clinica Universitaria de Navarra

🇪🇸

Pamplona, Spain

Hospital Clinico Universitario de Santiago de Compostela

🇪🇸

Santiago de Compostela, Galicia, Spain

Hospital del Mar

🇪🇸

Barcelona, Spain

Hospital Nuestra Señora de Sonsoles

🇪🇸

Avila, Spain

Hospital Universitario Reina Sofia

🇪🇸

Córdoba, Spain

Hospital de la Santa Creu i Sant Pau

🇪🇸

Barcelona, Spain

Hospital Vall D´Hebron

🇪🇸

Barcelona, Spain

Hospital General Universitario de Elche

🇪🇸

Elche, Spain

MD Anderson International Espana

🇪🇸

Madrid, Spain

Hospital General Universitario Gregorio Marañon

🇪🇸

Madrid, Spain

Centro Integral Oncológico Clara Campal

🇪🇸

Madrid, Spain

Althaia: Xarxa Assistencial de Manresa

🇪🇸

Manresa, Spain

Hospital Universitario Puerta de Hierro

🇪🇸

Majadahonda, Spain

Hospital General Carlos Haya

🇪🇸

Málaga, Spain

Hospital Son Espases

🇪🇸

Palma de Mallorca, Spain

Fundación Hospital Manacor

🇪🇸

Palma de Mallorca, Spain

Corporació Sanitaria Parc Taulí

🇪🇸

Sabadell, Spain

Hospital Virgen del Rocio

🇪🇸

Sevilla, Spain

Hospital Mutua de Terrassa

🇪🇸

Terrassa, Spain

Hospital Universitario Miguel Servet

🇪🇸

Zaragoza, Spain

Bristol Haematology & Oncology Centre

🇬🇧

Bristol, UK, United Kingdom

University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital

🇬🇧

Birmingham, United Kingdom

Velindre Hospital

🇬🇧

Cardiff, United Kingdom

Beatson West of Scotland Cancer Centre

🇬🇧

Glasgow, United Kingdom

Leeds Teaching Hospitals NHS Trust, St James's University Hospital

🇬🇧

Leeds, United Kingdom

St Bartholomews Hospital

🇬🇧

London, United Kingdom

St Mary's Hospital

🇬🇧

London, United Kingdom

Christie Hospital

🇬🇧

Manchester, United Kingdom

Plymouth Hospitals NHS Trust, Derriford Hospital

🇬🇧

Plymouth, United Kingdom

University of Southampton

🇬🇧

Southampton, United Kingdom

Royal Marsden Hospital

🇬🇧

Sutton, United Kingdom

The Clatterbridge Cancer Centre NHS Foundation Trust

🇬🇧

Wirral, United Kingdom

Cedars-Sinai Medical Center

🇺🇸

Los Angeles, California, United States

San Diego Clinical Trials

🇺🇸

San Diego, California, United States

Sharp Memorial Hospital

🇺🇸

San Diego, California, United States

VA San Diego Healthcare System

🇺🇸

San Diego, California, United States

Jesse Brown VA

🇺🇸

Chicago, Illinois, United States

Maryland Prostate Center

🇺🇸

Baltimore, Maryland, United States

Greater Baltimore Medical Center

🇺🇸

Baltimore, Maryland, United States

Union Memorial Hospital

🇺🇸

Baltimore, Maryland, United States

Dana Farber Cancer Institute

🇺🇸

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center

🇺🇸

Boston, Massachusetts, United States

University of Cincinnati Medical Center

🇺🇸

Cincinnati, Ohio, United States

Comprehensive Cancer Centers of Nevada

🇺🇸

Las Vegas, Nevada, United States

Regional Cancer Care PA

🇺🇸

Durham, North Carolina, United States

Durham VA Medical Center

🇺🇸

Durham, North Carolina, United States

University Hospitals Case Medical Center

🇺🇸

Cleveland, Ohio, United States

Cleveland Clinic Foundation

🇺🇸

Cleveland, Ohio, United States

Columbus Urology Research

🇺🇸

Columbus, Ohio, United States

Fox Chase Cancer Center

🇺🇸

Philadelphia, Pennsylvania, United States

UPMC Cancer Pavillion

🇺🇸

Pittsburgh, Pennsylvania, United States

Urology Clinics of North Texas

🇺🇸

Dallas, Texas, United States

Mary Crowley Cancer Research Center

🇺🇸

Dallas, Texas, United States

Virginia Mason Medical Center

🇺🇸

Seattle, Washington, United States

St. Alexius Medical Center

🇺🇸

Bismarck, North Dakota, United States

Aalborg Sygehus

🇩🇰

Aalborg, Denmark

Frederiksberg Hospital

🇩🇰

Frederiksberg, Denmark

Rigshospitalet

🇩🇰

Copenhagen, Denmark

Herlev Hospital

🇩🇰

Herlev, Denmark

Holstebro Sygehus

🇩🇰

Holstebro, Denmark

Storstrømmens Sygehus Næstved

🇩🇰

Næstved, Denmark

Skejby Sygehus

🇩🇰

Århus N, Denmark

The Urology Center of Colorado

🇺🇸

Denver, Colorado, United States

Urology Associates, PC

🇺🇸

Nashville, Tennessee, United States

Salt Lake Research

🇺🇸

Salt Lake City, Utah, United States

University of Utah

🇺🇸

Salt Lake City, Utah, United States

Queen's University at Kingston

🇨🇦

Kingston, Ontario, Canada

Princess Margaret Hospital

🇨🇦

Toronto, Ontario, Canada

University of Colorado

🇺🇸

Aurora, Colorado, United States

James A Haley Veteran Affairs Medical Center

🇺🇸

Tampa, Florida, United States

Walter Reed Army Medical Center

🇺🇸

Bethesda, Maryland, United States

National Cancer Institute - Center for Cancer Research

🇺🇸

Bethesda, Maryland, United States

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

GU Research Network, LLC

🇺🇸

Omaha, Nebraska, United States

Nebraska Cancer Specialists

🇺🇸

Omaha, Nebraska, United States

Medical College of Wisconsin

🇺🇸

Milwaukee, Wisconsin, United States

Hospital Universitario Fundación Alcorcón

🇪🇸

Madrid, Spain

The Royal Marsden

🇬🇧

London, United Kingdom

Sydney Haematology and Oncology Clinic

🇦🇺

St Leonards, New South Wales, Australia

University of Surrey

🇬🇧

Guildford, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath